Source URL: https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-canada-ltd-and-ibm-canada-announce-first-its-kind-collaboration

Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Blockchain technology has the potential to improve trust, transparency, patient safety and patient empowerment in clinical trials

To read the full press release please follow the following link of BI Canada:

https://www.boehringer-ingelheim.ca/en/press-release/boehringer-ingelheim-canada-ltd-and-ibm-canada-announce-first-its-kind-collaboration?

Media contact

Dr Reinhard Malin

Media Contact

Phone	+49 6132 77 90815
Mobile	+49 151 150 20690
Fax	+49 6132 77 6601

› E-mail press@boehringer-ingelheim.com

Binger Strasse 173
55216 Ingelheim am Rhein
GERMANY